HER2阳性乳腺癌的辅助性曲妥珠单抗治疗 - Suppr

Adjuvant trastuzumab in HER2-positive breast cancer.

Collins Ian, Francis Prudence, Mileshkin Linda

N Engl J Med. 2012 Feb 16;366(7):664; author reply 664-6. doi: 10.1056/NEJMc1112823.

Abstract

摘要

N Engl J Med. 2012 Feb 16;366(7):664; author reply 664-6. doi: 10.1056/NEJMc1112823.

N Engl J Med. 2012 Feb 16;366(7):663; author reply 664-6. doi: 10.1056/NEJMc1112823.

N Engl J Med. 2012 Feb 16;366(7):663-4; author reply 664-6. doi: 10.1056/NEJMc1112823.

N Engl J Med. 2012 Feb 16;366(7):664; author reply 664-6. doi: 10.1056/NEJMc1112823.

N Engl J Med. 2011 Oct 6;365(14):1336-8. doi: 10.1056/NEJMe1101326.

Lancet. 2010 Jan 30;375(9712):377-84. doi: 10.1016/S0140-6736(09)61964-4.

Clin Adv Hematol Oncol. 2003 Apr;1(4):237.

Clin Breast Cancer. 2008 Aug;8(4):324-33. doi: 10.3816/CBC.2008.n.037.

Bull Cancer. 2007;94(7 Suppl):F147-70.

J Clin Oncol. 2003 Jan 1;21(1):46-53. doi: 10.1200/JCO.2003.03.124.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。